CRISPR-Cas9 technology and its application in haematological disorders

Area of Science:

• Biotechnology
• Genetics
• Molecular Biology

Background:

• The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-CRISPR associated protein 9 (Cas9) system has emerged as a powerful tool for precise genome editing.
• CRISPR-Cas9 technology enables gene correction, mutation removal, and therapeutic gene insertion in human cells, revolutionizing research in hematology and oncology.

Purpose of the Study:

• To review the latest applications of CRISPR-Cas9 technology in hematological disorders.
• To discuss the current challenges and future directions for CRISPR-Cas9-mediated gene therapy in hematology.

Main Methods:

• Literature review of recent advancements in CRISPR-Cas9 technology.
• Analysis of CRISPR-Cas9 applications in inherited hematological disorders and malignancies.
• Discussion of delivery systems, efficiency, specificity, and ethical considerations.

Main Results:

• CRISPR-Cas9 technology is a valuable tool for studying molecular mechanisms in hematological malignancies.
• Inherited hematological disorders are ideal targets for CRISPR-Cas9-mediated gene therapy.
• Correction of disease-causing mutations could alleviate symptoms of hematological disorders.

Conclusions:

• CRISPR-Cas9 technology has significant potential for treating hematological disorders and advancing cancer research.
• Further research is needed to optimize delivery systems for higher efficiency and specificity.
• Establishing ethical guidelines and ensuring controllable safety are crucial before human application.